Biomedicine & Pharmacotherapy · 2023 · 11 citations · 17 references
MedicineNeurosciencePharmacologyApoptosisInflammationMolecular NeuroscienceAnti-inflammatory PharmacologyApoptosis PharmacologyNeuroinflammationNeuroprotectionNeuroprotective PharmacologySpinal Cord InjuryAnti-apoptotic ModulationAnti-inflammatory Natural ProductsAnti-inflammatory TherapeuticsCamp SignalingLocal Tissue ResponseNeuroprotective SignalingSpinal Cord Injury NeuroprotectionSpinal Cord Injury Pathology
Spinal cord injury (SCI) is a debilitating condition that results in significant impairment of motor function and sensation. Despite the ongoing efforts to develop effective treatments, there are currently very limited options available for patients with SCI. Celastrol, a natural anti-inflammatory compound extracted from Tripterygium wilfordii, has been shown to exhibit anti-inflammatory and anti-apoptotic properties. In this study, we aimed to explore the therapeutic potential of celastrol for SCI and elucidate the underlying molecular mechanisms involved. We found that local tissue often experiences a significant decrease in cAMP content and occurrs apoptosis after SCI. However, the treatment of celastrol could promote the production of cAMP by up-regulating the VIP-ADCYAP1R1-GNAS pathway. This could effectively inhibit the phosphorylation of JNK and prevent apoptosis, ultimately improving the exercise ability after SCI. Together, our results reveal celastrol may be a promising therapeutic agent for the treatment of SCI.
17
Xi Chen, Ying Zhao, Wu Luo et al. · Theranostics · 2020 · 289 citations · Full text
Medicine, Oncology, Pharmacology +17
Celastrol Attenuates Angiotensin II–Induced Cardiac Remodeling by Targeting STAT3
Shiju Ye, Wu Luo, Zia A. Khan et al. · Circulation Research · 2020 · 255 citations
Medicine, Cardiology, Pharmacology +15
Chenyu Zhang, Miao Zhao, Bingwei Wang et al. · Redox Biology · 2021 · 190 citations · Full text
Medicine, Neurobiology, Neuroscience +17